bpc-157 tga approval status FDA Status: Is It Approved for Human Use? What no one's telling you
Description
The lack of highly effective treatments for many peripheral neuropathies creates clinical need for novel therapeutics
This means that while oral BPC-157 has lower systemic bioavailability than injectable, its local bioavailability within the GI tract is exceptionally high
Uses in medicine People who may require thiamin to treat low levels of vitamin B1 include those with peripheral neuropathy, an inflammation of the nerves outside the brain
Tier 1: Research peptides ($30-$100 per vial)
